Dallas, TX, March 02, 2017 --(PR.com
)-- The global spine biologics market is expected to reach USD 2.7 billion by 2022 at a CAGR of 4.4% from 2016 to 2022.
The Global Spine Biologics market is segmented on the basis of product type, surgery type and geography.
On the basis of the product segment is categorized into bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others.
The surgery type segment is categorized into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.
On the basis of end-users the market is segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.
On the basis of region, the global spine biologics market report studies major regions, such as North America, Europe, South America, Asia-Pacific, and Rest of the World (RoW). North America contributed the largest share of 69.3% to the global spine biologics market, followed by Europe. The North American spine biologics market has witnessed significant growth in the recent years, as a result of the increased population, rise in awareness of newly developed technologies, increased per capita income, and improved medical literacy and tourism, among others. The increasing ageing population and growing health concerns have led governments across the region to take several initiatives, thereby resulting in growth in the market.
Request for sample pages: https://databridgemarketresearch.com/reports/global-spine-biologics-market/
Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Read more: https://databridgemarketresearch.com/spine-biologics-market-poised-grow-4-3/
The key players operating in this market are Arthrex, Inc., Cesca Therapeutics, Inc., DepuySynthes, Inc., DMP Spine, Exactech, Inc., K2m, Inc., Lattice Biologics, Medtronic, Nuo Therapeutics, Inc., Nutech, Nuvasive, Inc., Orthofix Holdings, Inc., Regen Lab Sa, RTI Surgical, Inc., Stryker Corporation, Wright Medical Technology, Inc., X-Spine Systems, Inc., Zimmer Holdings, Inc., and others.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Office Number 317, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Toll Free: +1-888-387-2818
LinkedIn: https://www.linkedin.com/company/data-bridge-market research?trk=nav_account_sub_nav_company_admin